SeraCare partners with AccuRef, Bayer

SeraCare Life Sciences announced an exclusive partnership with AccuRef Diagnostics, a division of Applied StemCell, to market and sell AccuRef’s portfolio of CRISPR-engineered cell line reference materials alongside the Seraseq portfolio of NGS cancer products. Customers will be able to purchase AccuRef cancer reference materials directly from SeraCare worldwide, with the exception of China, beginning in January.

Click to see full article